Measles Cases Decline in Europe, Central Asia
Analysis based on 16 articles · First reported Feb 10, 2026 · Last updated Feb 11, 2026
While measles cases in Europe and Central Asia saw a significant decline in 2025, the persistent risk of outbreaks highlights ongoing public health challenges. This situation could lead to increased demand for vaccines and related healthcare services, potentially benefiting pharmaceutical companies and healthcare providers involved in immunization efforts.
Measles cases in the WHO European Region, encompassing Europe and Central Asia, dropped by nearly 75% in 2025 compared to 2024, with 33,998 cases reported. Despite this reduction, the number of cases remains higher than most years since 2000, and some countries experienced increases. UNICEF and the World Health Organization warn that the risk of fresh outbreaks persists due to insufficient vaccination coverage and misinformation. The European_Regional_Verification_Commission for Measles and Rubella Elimination noted a setback, with 19 countries experiencing ongoing or re-established endemic transmission in 2024, up from 12. Both organizations, supported by partners like GAVI and the European Union, are working with governments to strengthen immunization programs, surveillance, and outbreak response to achieve the 95% vaccination coverage needed for herd immunity.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard